Response to Croteau and Barkin

Am J Gastroenterol. 2017 Oct;112(10):1617. doi: 10.1038/ajg.2017.256.

Authors

Brooks D Cash¹, Brian E Lacy², Philip S Schoenfeld³, Leonard S Dove⁴, Paul S Covington⁵

Affiliations

¹ University of South Alabama, Mobile, Alabama, USA.
² Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
³ University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
⁴ Allergan plc, Parsippany, New Jersey, USA.
⁵ Furiex Pharmaceuticals, Allergan plc, Parsippany, New Jersey, USA.

PMID: 28978962
DOI: 10.1038/ajg.2017.256

No abstract available

Publication types

Comment

MeSH terms

Humans
Imidazoles
Irritable Bowel Syndrome*
Phenylalanine / analogs & derivatives

Substances

Imidazoles
eluxadoline
Phenylalanine